The Latest Breaking News from FDA

Attorneys general across the U.S. have a new fight on their hands: protecting Americans from unproven and expensive stem cell treatments that salespeople claim can cure almost anything

The recent Supreme Court ruling on technical grounds has upheld the availability of the abortion pill mifepristone in the United States. While this decision is a temporary win for abortion rights advocates, it is not the final word on the issue, and there are indications that opponents of abortion will…

‘Civil War’ star credits intermittent fasting for his recent weight loss

The justices unanimously rejected the mifepristone case on technical grounds. Their ruling is not the victory it may seem

The Nasdaq and S&P 500 hit record highs on tame inflation and as Apple, Broadcom and Oracle soared on news. But the stock market gains were narrow.

The low-calorie sweetener is often marketed as a healthy glucose alternative.

The justices agreed that the plaintiffs didn't have standing to sue on the issue.

On June 13, 2024, the Supreme Court of the United States unanimously decided to uphold access to mifepristone, one of two pills used in medication abortion. Mifepristone has long been used safely and effectively in medication abortions around the world.

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

Justices unanimously upheld access to mifepristone, but Missouri, Idaho and Kansas are likely to revive the case

The Court ducks the conscience theory of standing based on the government's new position, "abandons" Haven's Realty, and starts the deadpool for associational standing